Prognostic factors in metastatic germ‐cell cancer

Beyer, J. (2019). Prognostic factors in metastatic germ‐cell cancer. Andrology, 7(4), pp. 475-478. Wiley 10.1111/andr.12615

[img] Text
2019 Andrology Review Beyer Prognostic Factors.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (119kB) | Request a copy

Determining stage and anticipating prognosis are the two crucial steps after the diagnosis of a germ-cell cancer that both guide subsequent treatment decisions. This review focuses on metastatic disease, which means germ-cell cancers beyond stage I limited to the testis. In the past, major centers developed separate staging and prognostic classifications for metastatic germ-cell cancer, which heavily impaired communication and comparisons across clinical trials. More recently, the classification system of the International Germ-Cell Cancer Collaborative Group (IGCCCG) has found acceptance worldwide and is currently being updated.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Beyer, Jörg

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2047-2919

Publisher:

Wiley

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

31 Oct 2019 14:12

Last Modified:

31 Oct 2019 14:12

Publisher DOI:

10.1111/andr.12615

PubMed ID:

30969027

BORIS DOI:

10.7892/boris.134291

URI:

https://boris.unibe.ch/id/eprint/134291

Actions (login required)

Edit item Edit item
Provide Feedback